Skip to content

Clinical study for integrated traditional Chinese and western medicine in preventing and treating pcos: a randomized controlled trial

Clinical study for integrated traditional Chinese and western medicine in preventing and treating pcos: a randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003302
Enrollment
Unknown
Registered
2020-05-14
Start date
2016-01-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovarian syndrome

Interventions

Sponsors

Jiangsu Province Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
19 Years to 38 Years

Inclusion criteria

Inclusion criteria: 1. Met the diagnostic criteria of PCOS, aged 19-38 years. 2. PCOS combined with ovulatory dysfunction infertility;PCOS with hyperandrogenemia;PCOS was associated with obesity and insulin resistance.PCOS with acne;In addition to the PCOS diagnostic criteria, the diagnosis criteria of acne, obesity and ovulatory dysfunction infertility were met. 3. Have good compliance, agree to enter the study, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. History of ovarian cyst, ovarian tumor, ovarian surgery, history of chemoradiotherapy, endometriosis, hyperthyroidism/hypothyroidism, hyperprolactinemia and other endocrine diseases, chromosome abnormalities. 2. Severe primary diseases including acute infectious diseases, cardiovascular diseases, kidney diseases, liver diseases and hematopoietic diseases. 3. Persons with mental illness or unable to give full informed consent due to mental or behavioral disorders. 4. Allergic constitution or allergic to a variety of drugs. 5. Those who were treated with hormone drugs within 3 months. 6. Those who do not take drugs as prescribed, cannot judge the efficacy or the incomplete data affect the efficacy or safety judgment.

Design outcomes

Primary

MeasureTime frame
fasting blood-glucose;sex hormone;fasting insulin;

Secondary

MeasureTime frame
Ovulation number;rate of abortion;ovulation rate;Menstrual cycle days;clinical pregnancy rate;

Countries

China

Contacts

Public ContactYong Tan

Department of Reproductive Medicine, Jiangsu Province Traditional Chinese Medicine Hospital

13951942495@163.com+86 13951942495

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026